New publication, Key Developments in Novel Therapies for Bleeding Disorders

The CHS, in collaboration with the Irish Haemophilia Society, is producing a new print publication, Key Developments in Novel Therapies for Bleeding Disorders. It is intended for a general audience—people with bleeding disorders and their families as well as health care providers—who would like a simple and concise summary of the most recent key developments in coagulation therapies to treat inherited bleeding disorders. The publication reports on clinical trial results and post-commercialization research in treatments for hemophilia A and B, von Willebrand disease, rare factor deficiencies and platelet function disorders. It will be published twice a year. https://www.hemophilia.ca/wp-content/uploads/2026/04/Key-Developments-in-Novel-Therapies-for-Bleeding-Disorders-2026-1.pdf